TrialThe oncologist2019
Alternate Endpoints for Phase II Trials in Advanced Neuroendocrine Tumors.
Hiroshi Imaoka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it
TrialThe oncologist2019
Hiroshi Imaoka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.